Article

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

2022-06-23

Abstract excerpt

<title>Abstract</title> <p>Administration of targeted therapies provides a promising treatment strategy for rare cancers such as urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma (PBAC), however, the selection of appropriate drugs remains difficult. Therefore, in the present study, we aimed to establish a routine compatible methodological pipeline for the identification of the most important therapeu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5e4aaff8-6ac5-57df-9a7b-9e50a264ff90
DOI: 10.21203/rs.3.rs-1757372/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomasDOI 10.21203/rs.3.rs-1757372/v1Read

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.Semantic proximity Read

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.Semantic proximity Read

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.Semantic proximity Read

Molecular Profiling of Bladder Adenocarcinoma Using a National Genomics RepositorySemantic proximity Read

Actionable genomic landscapes from a real-world cohort of urothelial carcinoma patients.Semantic proximity Read

The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers.Semantic proximity Read

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.Semantic proximity Read

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.Semantic proximity Read

Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.Semantic proximity Read

Significance and Mechanisms Analyses of RB1 Mutation in Bladder Cancer Disease Progression and Drug Selection by Bioinformatics AnalysisSemantic proximity Read

Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder CancerSemantic proximity Read